Skip to main content

Advertisement

Table 3 Estimated unadjusted and adjusted odds ratios (OR) with 95 percent confident intervals for the risk of death obtained from the dynamic logistic regression model and based on 1482 individuals in the CDM group alive after the first year of the follow-up

From: Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART

  Unadjusted OR 95% CI Adjusted OR 95% CI P-value
Adherence history:      
poor at least once vs optimal 2.14 (1.45, 3.14) 2.18 (1.47, 3.22) <0.001
non-response at least once vs optimal 2.16 (1.29, 3.52) 2.09 (1.22, 3.40) <0.001
missing at least once vs optimal 3.46 (2.07, 5.54) 3.65 (2.15, 5.92) 0.005
Pre-ART WHO disease stage      
stage 2 1(ref)   1(ref)   0.51
stage 3 1.67 (0.99, 3.03) 1.39 (0.82, 2.55)  
stage 4 1.61 (0.88, 3.08) 1.28 (0.68, 2.48)  
Pre ART CD4 cell count      
0-49 3.61 (1.88, 7.85) 3.43 (1.74, 7.62)  
50-99 2.75 (1.36, 6.14) 2.62 (1.28, 5.90)  
100-149 2.49 (1.20, 5.63) 2.45 (1.18, 5.57)  
150-199 1(ref)   1(ref)   0.01
Pre-ART Body mass index      
<20 1.63 (1.12, 2.38) 1.33 (0.90, 1.96)  
20-27 1(ref)   1(ref)   0.35
>27 0.98 (0.43, 1.93) 1.07 (0.46,2.15)  
Age at ART initiation groups      
18-35 1(ref)   1(ref)   0.07
35-50 0.72 (0.49, 1.05) 0.83 (0.56, 1.24)  
50+ 1.45 (0.74, 2.63) 1.74 (0.87, 3.21)  
Sex      
Female vs Male 0.62 (0.43, 0.90) 0.72 (0.49, 1.06) 0.10
Time since ART initiation in years      
≤2 1(ref)   1(ref)   0.13
2-3 1.65 (0.98, 2.84) 1.66 (0.98, 2.86)  
3-4 1.10 (0.61, 1.99) 1.10 (0.61, 1.98)  
4-5 1.64 (0.96, 2.86) 1.56 (0.90, 2.74)  
>5 0.91 (0.38, 1.96) 0.80 (0.33, 1.73)  
  1. Adherence history is given by 4 time-dependent indicators with “optimal” adherence as a reference class.